Filter by
 

Type of content

Publication date

Main subject

Main subject

Keywords

Keywords

Target audience

Search tool

Displaying 1 - 20 of 31

News

Latest European Web Survey on Drugs finds cannabis and ecstasy use most impacted by COVID-19

20.01.2022

New survey results released today by the EU drugs agency (EMCDDA) reveal that cannabis and ecstasy use are the drug-consumption patterns most impacted by COVID-19 restrictions (1). The European Web Survey on Drugs found that, while herbal cannabis use increased, use of ‘party drug’ MDMA/ecstasy...

News

World AIDS Day: new EMCDDA miniguide on responding to drug-related infectious diseases

01.12.2021

Health and social responses to drug-related infectious diseases are explored today in a new EMCDDA miniguide, released to mark World AIDS Day. The resource is the eighth in a series of miniguides, making up the agency’s latest overview of actions and interventions to respond to the consequences of...

News

Malta and Luxembourg announce plans for limited cultivation and use of cannabis

25.11.2021

On 4 October 2021 the equalities minister in Malta presented a bill to change laws on cannabis. This follows the government’s election manifesto of 2017, which pledged to launch a debate on recreational cannabis, and a white paper, published in March 2021, that reflected the ‘government’s vision...

News

Lisbon Addictions is back! Registration and call for abstracts open today

25.10.2021

Leading international experts in the field of addiction science will gather in Lisbon from 23–25 November 2022 for the next European Conference on Addictive Behaviours and Dependencies (‘Lisbon Addictions 2022’). Under the overarching theme of Global Addictions, the event will showcase the latest...

News

Methamphetamine from Afghanistan: ‘signals indicate that Europe should be better prepared’, says new EMCDDA report

29.09.2021

This report was prepared before recent developments in Afghanistan and before the withdrawal of US military and other NATO allies from the country. The findings of this report are preliminary and will need to be reviewed and updated as more information becomes available from the region. Europe...

News

New report highlights public health and social risks posed by synthetic cannabinoids in Europe

09.09.2021

Synthetic cannabinoids come under the spotlight today in a new report released by the EU drugs agency (EMCDDA). Widely available across Europe and highly potent, these substances are placing some users at a ‘high risk of poisoning’, the agency warns. Synthetic cannabinoids are the largest group of...

News

EMCDDA Best practice portal update (3/2021)

07.07.2021

Contingency Management – evidence continues to build-up, time to start talking about implementation? According to the just published EMCDDA European Drug Report cocaine is the second most commonly used illicit drug in Europe and the number of people entering treatment for the first time has risen...

News

New EMCDDA report underlines need to scale up drug services in prisons

25.06.2021

Current insights and future challenges on drugs and prison in Europe are explored today in a major new study published by the EU drugs agency (EMCDDA)(1). Released on the eve of International day against drug abuse and illicit trafficking, the report, Prison and drugs in Europe: current and future...

News

Council approves EU Drugs Action Plan 2021–2025

22.06.2021

The Council of the EU (Foreign Affairs) approved on 21 June the EU Drugs Action Plan for 2021–2025. The new plan presents the concrete actions needed to achieve the priorities of the EU Drugs Strategy, adopted in December 2020 (1). The action plan sets out a specific timetable for these actions, a...

News

What are the lessons to be learnt from the European Drug Report 2021?

09.06.2021

The new EU Drugs Strategy 2021–25 makes explicit that the European response to drugs should be evidence-based and delivered through a balanced and integrated approach, which ultimately must be judged on its impact on the health, safety and wellbeing of our citizens. The European Monitoring Centre...

News

New report highlights public health risks and increasing availability of ‘designer benzodiazepines’ in Europe

09.06.2021

New benzodiazepines, which are not controlled by international drug laws, come under the spotlight today in a new report released by the EU drugs agency (EMCDDA) (1). Often marketed as ‘designer benzodiazepines’, these substances are sold as ‘legal’ replacements for controlled benzodiazepines and...

News

Latest wastewater data reveal drug-taking habits in a record 82 European cities

18.05.2021

The 2020 findings from the largest European project in the science of wastewater analysis are revealed today in Wastewater analysis and drugs — a European multi-city study, published by the Europe-wide SCORE group, in association with the EU drugs agency (EMCDDA) (1)(2). The project analysed...

News

Legalisation of cannabis in 3 US states: New York, Virginia, New Mexico

04.05.2021

In the last few weeks, three US states have legalised cannabis for recreational purposes, all via the legislature and not via public ballots. New York, Virginia and New Mexico will begin by permitting cannabis use in private and home cultivation, for adults aged over 21 (out of sight and away from...

News

EMCDDA releases third trendspotter study on COVID-19 and drugs

30.04.2021

In the third in its series of rapid ‘trendspotter’ studies, the EMCDDA explores the impact of COVID-19 on the drug situation and responses to it. Revisiting and reviewing findings from two studies in 2020 on the effects of the pandemic on drug use and services, the report identifies new trends and...

News

EMCDDA Best practice portal update (2/2021)

15.04.2021

School-based programmes to improve mental health and well-being and reduce risks Adolescents spend a significant part of their lifetime in school and, therefore, this environment plays an important role in their social, emotional and psychological development. Psychological distress can appear...

News

EMCDDA launches 2021 European Web Survey on Drugs to assess patterns of drug use in over 30 countries

18.03.2021

Do you use drugs? How many? How often? These are among the questions posed in the latest European Web Survey on Drugs, launched today by the EU drugs agency (EMCDDA). Targeted at people, aged 18 and over, who have used drugs, the survey aims to improve understanding of patterns of drug use in...

News

EMCDDA enters new phase as it embarks on 2021 activities

29.01.2021

This year, the EMCDDA will embark on a new five-year Roadmap under its Strategy 2025, kicking off with an ambitious range of activities for the period 2021–23. We enter this new phase amid major uncertainty, when the long-term impact of the COVID-19 pandemic remains largely unknown. In such times,...

News

EMCDDA kicks off new wave of webinars for 2021

27.01.2021

The EMCDDA will be kicking off its 2021 programme of webinars on 3 February starting with the topic ‘Responding to drugs and homelessness: innovative approaches in Europe’. The link between long-term homelessness, problem drug use and alcohol dependence is well documented. As the COVID-19 pandemic...

News

Bursaries for students from European Neighbourhood Policy countries for the 2021 European Drugs Winter and Summer Schools

26.01.2021

Professionals, academics or experts from European Neighbourhood Policy (ENP) countries (1) will have an opportunity to participate in the European Drugs Winter and Summer Schools this year, thanks to 10 bursaries being offered through the EU4Monitoring Drugs (EU4MD) project. The University...

News

Bursaries for Western Balkan students for the 2021 European Drugs Winter School

25.01.2021

Professionals, academics and experts from the Western Balkan region will have an opportunity to participate in the first European Drugs Winter School (EDWS) this year, thanks to six bursaries being offered through the EMCDDA Instrument for Pre-accession Assistance project (IPA 7). The course,...
Loading